Nisreen Soufi, MD

Assistant Professor of Clinical Pediatrics

Image of Nisreen Soufi, MD
Is this your profile? Click to edit

Publications

  • Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis JHEP Rep. 2023 Aug; 5(8):100782. . View in PubMed
  • Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease Hepatology. 2023 02 01; 77(2):530-545. . View in PubMed
  • Maralixibat for the treatment of PFIC: Long-term, IBAT inhibition in an open-label, Phase 2 study Hepatol Commun. 2022 09; 6(9):2379-2390. . View in PubMed
  • Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial Lancet Gastroenterol Hepatol. 2022 09; 7(9):830-842. . View in PubMed
  • Colorectal Dysplasia and Cancer in Pediatric-Onset Ulcerative Colitis Associated With Primary Sclerosing CholangitisClin Gastroenterol Hepatol. 2021 05; 19(5):1067-1070. e2. . View in PubMed
  • The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children Hepatology. 2021 03; 73(3):1074-1087. . View in PubMed
  • Modeling Outcomes in Children With Biliary Atresia With Native Liver After 2 Years of Age Hepatol Commun. 2020 Dec; 4(12):1824-1834. . View in PubMed
  • Severe Late-Onset Acute Cellular Rejection in a Pediatric Patient With Isolated Small Intestinal Transplant Rescued With Aggressive Immunosuppressive Approach: A Case Report Transplant Proc. 2019 Nov; 51(9):3181-3185. . View in PubMed
  • Post-Transplant Disease Recurrence in Pediatric PSC Curr Gastroenterol Rep. 2018 Aug 06; 20(9):44. . View in PubMed
  • Hepatology. 2018 10; 68(4):1644-1646. . View in PubMed
  • [Effect of N-3 polyunsaturated fatty acids on the modulation of T lymphocytes in vitro and redox status in obese women with hypertension] Ann Cardiol Angeiol (Paris). 2016 Jun; 65(3):126-30. . View in PubMed
  • Liver-specific loss of lipin-1-mediated phosphatidic acid phosphatase activity does not mitigate intrahepatic TG accumulation in mice J Lipid Res. 2015 Apr; 56(4):848-58. . View in PubMed
  • Inhibiting monoacylglycerol acyltransferase 1 ameliorates hepatic metabolic abnormalities but not inflammation and injury in mice J Biol Chem. 2014 Oct 24; 289(43):30177-88. . View in PubMed
  • Abrogating monoacylglycerol acyltransferase activity in liver improves glucose tolerance and hepatic insulin signaling in obese mice Diabetes. 2014 Jul; 63(7):2284-96. . View in PubMed